Micron Technology
MU
Alibaba
BABA
Broadcom
AVGO
Meta Platforms
META
NVIDIA
NVDA
US Stock MarketDetailed Quotes
DAWN Day One Biopharmaceuticals
- 10.035
- -1.785-15.10%
Trading Feb 26 14:15 ET
1.02BMarket Cap-9.84P/E (TTM)
11.090High10.020Low1.86MVolume10.410Open11.820Pre Close19.55MTurnover2.58%Turnover RatioLossP/E (Static)101.35MShares18.07052wk High2.02P/B722.53MFloat Cap10.02052wk Low--Dividend TTM72.00MShs Float28.699Historical High--Div YieldTTM9.05%Amplitude5.440Historical Low10.514Avg Price1Lot Size
Day One Biopharmaceuticals Key Stats
EPS
According to the latest financial report of Day One Biopharmaceuticals, the latest earnings per share (TTM) for the company is -0.69. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Day One Biopharmaceuticals's free cash flow? The latest report shows it as -31.43M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Day One Biopharmaceuticals shows that the company's current ratio is 7.66, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Day One Biopharmaceuticals, the quick ratio is 7.43, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Day One Biopharmaceuticals? The latest ROE figure is -12.42%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Day One Biopharmaceuticals, the total asset return on investment (ROA) is -11.10%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Day One Biopharmaceuticals's latest financial report to see how their gross margin is doing - currently at 89.79%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Day One Biopharmaceuticals, the net profit margin is -224.99%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.